Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

UnitedHealth Is Price Gouging Cancer Patients by Overcharging 'Thousands of Percent' for Live-Saving Meds, Pocketing Extra Billions: Feds

The UnitedHealth Group is overcharging patients for necessary life-saving drugs as a result of price gouging that increases the cost of such medication exponentially.

Latin Times

3 Niche Biotech Stocks Redefining Innovation

The biotech market offers great investment potential due to innovative advancements in genetic profiling, biologics, CRISPR technology, and rare disease treatments driving strong demand and growth. Therefore, investing in strong biotech stocks like Halozyme Therapeutics (HALO), BioMarin Pharmaceutical (BMRN), and United Therapeutics (UTHR) could be wise. Read on.

StockNews.com

NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance

NeoGenomics stock jumped Wednesday after the company issued a strong 2025 outlook. That partially reversed a recent selloff.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

At last, Britain has a legal drug consumption room – thanks to one man’s civil disobedience

Former heroin addict Peter Krykant set up a safe consumption van during Covid, at great personal cost. But his sacrifice paved the way for real change, says Birkbeck’s Kojo Koram

The Guardian - UK

Bayer Hit with $100 Million Verdict Over Toxic PCB Exposure

Bayer AG faces a $100 million jury verdict over PCB exposure at a Seattle school amid ongoing legal challenges related to toxic chemicals.

Mic

Is Aurinia Pharmaceuticals Poised for Growth in the Biotech Space?

Aurinia Pharmaceuticals (AUPH) released its third-quarter results, reporting solid revenue growth and robust cash flow from operations. Solid demand for its product offerings, restructuring strategies, and sound financials remain key drivers of the company’s growth and success. So, let’s analyze whether AUPH is a buy today. Read more to find…

StockNews.com

‘Positive feedback’ from first users of Glasgow's drugs consumption room

The UK’s first safer drug consumption room has had good uptake and “positive feedback” from users since opening in Glasgow, a minister has…

The National (Scotland)

Read news from The Economist, FT, and more,
with one subscription

‘Positive feedback’ from first users of safer drugs consumption room – minister

Neil Gray said the success of the Thistle Centre would be measured if there are fewer drug deaths and ‘harm reduction’.

Evening Standard

BridgeBio, ARS Pharma, Harmony Bio Shine At JPM. But SpringWorks, Beam Take Their Lumps.

Biotech stocks put up a split showing at JPM, where names like BridgeBio, ARS and Harmony stood out with strong preliminary reports.

Investors Business Daily

J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders

Johnson & Johnson will spend more than $14 billion to move deeper into treating central nervous system disorders by purchasing Intra-Cellular Therapies

The Independent UK

GSK to buy US cancer drug firm IDRx for up to $1.15bn

Massachusetts-based company is working on new treatments for gastrointestinal cancers

The Guardian - UK

Scotland's first safe drug consumption room has opened – here's how it works

SCOTLAND’S first safe drug consumption room has officially opened its doors in Glasgow on Monday ...

The National (Scotland)

From the Beatles to biologics – how Liverpool became a life science hotspot

The city has a long history with tropical medicine and is now home to one of the largest biotech clusters in Europe

The Guardian - UK

Ex-McKinsey partner pleads guilty to destroying records on opioids

Martin Elling pleads guilty to destroying records on advice provided to Purdue Pharma on how to ‘turbocharge’ sales

The Guardian - US

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

Swinney: Consumption room should help reduce ‘entirely unacceptable’ drug deaths

The First Minister has visited the UK’s first facility where drug users can inject in a clean and safe environment.

The Independent UK

USTR warns of risks from online pharmacies in its 'notorious markets' report

An annual U.S. government report on “notorious markets” known for counterfeiting and other violations of intellectual property says that nearly all 35,000 online pharmacies around the world are being run illegally

StockNews.com

3 Blue-Chip Stocks with Strong Buy Ratings from Analysts

As a wave of volatility has been re-introduced to the system, investors are flocking toward blue-chip companies for stability and long-term growth potential. Thus, one could consider adding these three fundamentally sound blue-chip stocks, AbbVie (ABBV), Merck & Co. (MRK), and Johnson & Johnson (JNJ), with Strong Buy ratings from…

Investors Business Daily

J&J Falls — While Boston Scientific, Medtronic Pop — After Strokes Sideline A Key Product

Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.

Get all your
news in one place.

100’s of premium titles.
One news app.

Kiplinger

Moderna Stock Is Volatile Amid Bird Flu Developments

Moderna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you need to know.

Investors Business Daily

8 Stocks' Huge Profit Growth Is About To Knock Your Socks Off

Looking for some truly wowing profit growth from S&P 500 companies. A few are likely to knock your socks off.

Investors Business Daily

Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike

Moderna stock surged Tuesday after the Centers for Disease Control and Prevention noted a two-week spike in positive Covid tests.

Investors Business Daily

Denali Reverses Its Fortunes With 'Too Early' Miss In ALS Treatment

Denali Therapeutics shares reversed higher on Tuesday after the drugmaker's ALS treatment failed in a six-month study.

Investors Business Daily

Globus Medical Stock Revs Up For Next Move After 70% Run

This leading medical device maker is showing constructive action in a flat base and setting up for its next move.

The Guardian - UK

Wegovy maker Novo Nordisk sponsored British pharmacies in pursuit of sales

Danish drug company gave money for Google ads to promote weight loss services and received data on web traffic and prescriptions

Investors Business Daily

How Tarsus Pharmaceuticals' Unique Inspiration Is Driving A Triple-Digit Run

Tarsus Pharmaceuticals drew its inspiration from animal-health drugs. Now, the biotech stock is on a triple-digit run.

1 … 11 12 13 14

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

SP Global Market Intelligence

Read news from The Economist, FT, and more,
with one subscription

Topics

Intellectual Property

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.